141 related articles for article (PubMed ID: 3020312)
21. Effect of different calcium channel blockers on angiotensin II- and vasopressin-induced prostacyclin biosynthesis in vascular smooth muscle cells.
Vallotton MB; Gerber-Wicht C; Dolci W; Rivest RW
J Cardiovasc Pharmacol; 1990 Apr; 15(4):598-603. PubMed ID: 1691390
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Becker RH; Schölkens BA; Metzger M; Schulze KJ
Arzneimittelforschung; 1984; 34(10B):1411-6. PubMed ID: 6097267
[TBL] [Abstract][Full Text] [Related]
23. A symposium: Ramipril--a new angiotensin converting enzyme inhibitor. May 2-4, 1986, Brussels, Belgium. Proceedings.
Am J Cardiol; 1987 Apr; 59(10):1D-177D. PubMed ID: 3034015
[No Abstract] [Full Text] [Related]
24. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
Campbell WB; Gomez-Sanchez CE
Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Wiemer G; Popp R; Schölkens BA; Gögelein H
Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
[TBL] [Abstract][Full Text] [Related]
26. Actions of amiloride analogues on prostacyclin synthesis by rat aortic rings.
Ritter JM; Aksoy A; Cragoe EJ; Taylor GW
Br J Pharmacol; 1987 Dec; 92(4):857-62. PubMed ID: 3322464
[TBL] [Abstract][Full Text] [Related]
27. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
Metzger H; Maier R; Sitter C; Stern HO
Arzneimittelforschung; 1984; 34(10B):1402-6. PubMed ID: 6097265
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Schölkens BA; Becker RH; Kaiser J
Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
[TBL] [Abstract][Full Text] [Related]
29. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
[TBL] [Abstract][Full Text] [Related]
30. Ramipril: review of pharmacology.
Becker RA; Schölkens B
Am J Cardiol; 1987 Apr; 59(10):3D-11D. PubMed ID: 3034030
[TBL] [Abstract][Full Text] [Related]
31. Role of endothelium, oxygen and ionic milieu in the prostacyclin and thromboxane production of rat aortic tissue slices.
Nádasy GL; Székács B; Juhász I; Fehér J; Kovách AG; Monos E
Acta Physiol Hung; 1991; 78(1):77-87. PubMed ID: 1763652
[TBL] [Abstract][Full Text] [Related]
32. Converting enzyme inhibition in kinin-deficient brown Norway rats.
Danckwardt L; Shimizu I; Bönner G; Rettig R; Unger T
Hypertension; 1990 Oct; 16(4):429-35. PubMed ID: 2145220
[TBL] [Abstract][Full Text] [Related]
33. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Farhy RD; Carretero OA; Ho KL; Scicli AG
Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
[TBL] [Abstract][Full Text] [Related]
34. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia.
Rambausek M; Mall G; Kollmar S; Ritz E
Kidney Int Suppl; 1988 Sep; 25():S201-3. PubMed ID: 2972864
[No Abstract] [Full Text] [Related]
35. Stimulation of prostacyclin synthesis in vascular cells by mononuclear cell products.
Dejana E; Breviario F; Balconi G; Rossi V; Remuzzi G; de Gaetano G; Mantovani A
Blood; 1984 Dec; 64(6):1280-3. PubMed ID: 6388665
[TBL] [Abstract][Full Text] [Related]
36. The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta.
Düsing R; Scherhag R; Landsberg G; Glänzer K; Kramer HJ
Eur J Pharmacol; 1983 Aug; 91(4):501-4. PubMed ID: 6352286
[TBL] [Abstract][Full Text] [Related]
37. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
38. Prostacyclin-mediated protection by angiotensin-converting enzyme inhibitors against injury of aortic endothelium by free radicals.
Liao DF; Chen X
Cardioscience; 1992 Jun; 3(2):79-84. PubMed ID: 1379480
[TBL] [Abstract][Full Text] [Related]
39. Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations.
Schölkens BA; Xiang JZ; Tilly H
Clin Exp Hypertens A; 1984; 6(10-11):1807-13. PubMed ID: 6099766
[No Abstract] [Full Text] [Related]
40. Angiotensin converting enzyme inhibitors (captopril, CGS14831 and CGS14824A) antagonise in vitro smooth muscle prostanoid synthesis: evidence for calcium channel blockade.
Jeremy JY; Mikhailidis DP; Dandona P
Agents Actions; 1988 Jul; 24(3-4):381-6. PubMed ID: 3140614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
